Literature DB >> 16011457

Defective glucose homeostasis during infection.

Owen P McGuinness1.   

Abstract

Infection leads to profound alterations in whole-body metabolism, which is characterized by marked acceleration of glucose, fat and protein, and amino acid flux. One of the complications of infection, especially in the nutritionally supported setting, is hyperglycemia. The hyperglycemia is caused by peripheral insulin resistance and alterations in hepatic glucose metabolism. The defects in hepatic glucose metabolism include overproduction of glucose and a failure of the liver to appropriately adapt when nutritional support is administered. Investigators have suggested that multiple factors contribute to the observed defects. In this review, I focus primarily on alterations in carbohydrate metabolism, examining both the metabolic response to infection and inflammatory stress, the role of the accompanying neuroendocrine and inflammatory responses in the metabolic response, and the interaction between the endocrine response to infection and nutritional support.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011457     DOI: 10.1146/annurev.nutr.24.012003.132159

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  29 in total

1.  Central and peripheral cytokines mediate immune-brain connectivity.

Authors:  Hugo O Besedovsky; Adriana del Rey
Journal:  Neurochem Res       Date:  2010-09-04       Impact factor: 3.996

2.  Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Authors:  Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

Review 3.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

Review 4.  The spectrum of T cell metabolism in health and disease.

Authors:  Glenn R Bantug; Lorenzo Galluzzi; Guido Kroemer; Christoph Hess
Journal:  Nat Rev Immunol       Date:  2017-09-25       Impact factor: 53.106

5.  Estimating glucose requirements of an activated immune system in growing pigs.

Authors:  S K Kvidera; E A Horst; E J Mayorga; M V Sanz-Fernandez; M Abuajamieh; L H Baumgard
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

6.  NF-κB-dependent airway inflammation triggers systemic insulin resistance.

Authors:  Travis J Cyphert; Robert T Morris; Lawrence M House; Tammy M Barnes; Yolanda F Otero; Whitney J Barham; Raphael P Hunt; Rinat Zaynagetdinov; Fiona E Yull; Timothy S Blackwell; Owen P McGuinness
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-09-16       Impact factor: 3.619

Review 7.  Physiologic action of glucagon on liver glucose metabolism.

Authors:  C J Ramnanan; D S Edgerton; G Kraft; A D Cherrington
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

8.  Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: a report from the national registry of cardiopulmonary resuscitation.

Authors:  David G Beiser; Gordon E Carr; Dana P Edelson; Mary Ann Peberdy; Terry L Vanden Hoek
Journal:  Resuscitation       Date:  2009-03-18       Impact factor: 5.262

9.  Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia.

Authors:  Yen-Yue Lin; Chin-Wang Hsu; Wayne Huey-Herng Sheu; Shi-Jye Chu; Chin-Pyng Wu; Shih-Hung Tsai
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

Review 10.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity.

Authors:  Amy R Johnson; J Justin Milner; Liza Makowski
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.